Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GLUE
#1875
Monte Rosa Therapeutics, Inc. Common Stock
17.750
0
-1.99%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-1.99%
Mudança mensal
-23.16%
Mudança em 6 meses
+57.08%
Mudança anual
+57.08%
Fechamento anterior
18.110
0
Open
17.750
0
Bid
Ask
Low
17.750
0
High
17.750
0
Volume
104
Mercados
Ações
Cuidados de saúde
GLUE
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
61.38 M
61.51 M
61.51 M
61.76 M
65.12 M
—
Valuation ratios
Enterprise value
—
202.62 M
206.88 M
209.11 M
274.18 M
892.79 M
Price to earnings ratio
-2.91
-7.08
38.67
11.28
20.58
63.44
Price to sales ratio
26.19
6.78
2.29
2.01
3.25
14.34
Price to cash flow ratio
7.53
12.21
7.91
7.29
-20.29
7.12
Price to book ratio
0.45
2.3
0.39
0.37
0.59
3.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
-0.03
0.12
0.03
0.06
0.18
Return on equity %
0.12
-0.06
0.17
0.05
0.11
0.27
Return on invested capital %
52.57
-31.88
69.64
28.06
124.95
190.77
Gross margin %
100
100
100
100
100
400
Operating margin %
287.84
-21.44
51.85
67.06
258.26
355.73
EBITDA margin %
—
—
—
—
—
—
Net margin %
258.89
-22.16
55.2
53.01
212.1
298.16
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.03
2.4
5.61
7.16
6.54
21.71
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.16
0.2
0.06
0.03
0.46
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.26
-0.61
0.55
0.42
-0.73
-0.37
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.53
3.03
0.95
3.54
4.75
12.27
Net current asset value per share
3.06
5.11
4.01
3.64
4.88
17.63
Tangible book value per share
2.51
3.02
3.32
3.26
2.98
12.58
Working capital per share
2.56
2.98
3.29
3.13
4.13
13.54
Book value per share
2.51
3.02
3.32
3.26
2.98
12.58
Notícias
Ações da Monte Rosa sobem com resultados de ensaio em câncer de próstata
Monte Rosa shares rise on prostate cancer trial results
Monte Rosa divulga dados positivos de ensaio clínico para medicamento contra câncer de próstata
Monte Rosa reports positive trial data for prostate cancer drug
NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates
Preço-alvo das ações da Monte Rosa elevado para US$ 37 de US$ 27,50 pela Piper Sandler
Monte Rosa stock price target raised to $37 from $27.50 at Piper Sandler
Monte Rosa Therapeutics precifica oferta pública de US$ 300 milhões
Monte Rosa Therapeutics prices $300 million public offering
GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug
Monte Rosa Therapeutics (GLUE) is on the Move, Here's Why the Trend Could be Sustainable
Monte Rosa Therapeutics lança oferta pública de US$ 200 milhões